Chapter 1 Approaches to Discovering Novel Antibacterial and Antifungal Agents

Methods in Enzymology

Volumn 458, Issue A, 2009, Pages 3-28

  Donadio, Stefano ^a,b   Monciardini, Paolo ^b   Sosio, Margherita ^a  

^a Ktedogen Srl   (Italy)

^b NAICONS Srl   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT;

ACTINOBACTERIA; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIUM ISOLATION; DATA BASE; DRUG ACTIVITY; DRUG COST; DRUG DETERMINATION; DRUG MANUFACTURE; DRUG PURIFICATION; DRUG SCREENING; DRUG SYNTHESIS; FOLLOW UP; FUNGAL STRAIN; FUNGUS ISOLATION; MICROBIAL DIVERSITY; PRESERVATION AND STORAGE; PRIORITY JOURNAL; REVIEW; SAMPLE; SOIL;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BIOLOGICAL PRODUCTS; MICROBIAL SENSITIVITY TESTS;

EID: 64249123522     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)04801-0     Document Type: Review

References (44)

1. Baltz R.H. Antibiotic discovery from actinomycetes: Will a renaissance follow the decline and fall?. SIM News 55 (2005) 186-196
2. Brandi L., Fabbretti A., La Teana A., Abbondi M., Losi D., Donadio S., and Gualerzi C.O. Specific, efficient, and selective inhibition of prokaryotic translation initiation by a novel peptide antibiotic. Proc. Natl. Acad. Sci. USA 103 (2006) 39-44
3. Brandi L., Fabbretti A., Milon P., Carotti M., Pon C.L., and Gualerzi C.O. Methods for identifying compounds that specifically target translation. Methods Enzymol. 431 (2007) 229-267
4. Bull A.T., Ward A.C., and Goodfellow M. Search and discovery strategies for biotechnology: The paradigm shift. Microbiol. Mol. Biol. Rev. 64 (2000) 573-606
5. Busch U., and Nitschko H. Methods for the differentiation of microorganisms. J. Chromatogr. B Biomed. Sci. Appl. 722 (1999) 263-278
6. Busti E., Cavaletti L., Monciardini P., Schumann P., Rohde M., Sosio M., and Donadio S. Catenulispora acidiphila gen. nov., sp. nov., a novel, mycelium-forming actinomycete, and proposal of Catenulisporaceae fam. nov. Int. J. Syst. Evol. Microbiol. 56 (2006) 1741-1746
7. Butler M.S. Natural products to drugs: Natural product-derived compounds in clinical trials. Nat. Prod. Rep. 25 (2008) 475-516
8. Chalker A.F., and Lunsford R.D. Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach. Pharmacol. Ther. 95 (2002) 1-20
9. Chan J.A., and Hueso-Rodríguez J.A. Compound library management. Methods Mol. Biol. 190 (2002) 117-127
10. Davis K.E.R., Joseph S.J., and Janssen P.H. Effects of growth medium, inoculum size, and incubation time on culturability and isolation of soil bacteria. Appl. Environ. Microbiol. 71 (2005) 826-834
11. De Pascale G., Grigoriadou C., Losi D., Ciciliato I., Sosio M., and Donadio S. Validation for high-throughput screening of a VanRS-based reporter gene assay for bacterial cell wall inhibitors. J. Appl. Microbiol. 103 (2007) 133-140
12. DeBacker M.D., Nelissen B., Logghe M., Viaene J., Loonen I., Vandoninck S., de Hoogt R., Dewaele S., Simons F.A., Verhasselt P., Vanhoof G., Contreras R., et al. An antisense-based functional genomics approach for identification of genes critical for growth of Candida albicans. Nat. Biotechnol. 19 (2001) 235-241
13. Dermyer M., Wise S.C., Braden T., and Holler T.P. Simultaneous screening of multiple bacterial tRNA synthetases using an Escherichia coli S30-based transcription and translation assay. Assay Drug Dev. Technol. 5 (2007) 515-521
14. DeVito J.A., Mills J.A., Liu V.G., Agarwal A., Sizemore C.F., Yao Z., Stoughton D.M., Cappiello M.G., Barbosa M.D., Foster L.A., et al. An array of target-specific screening strains for antibacterials discovery. Nat. Biotechnol. 20 (2002) 478-483
15. Donadio S., Brandi L., Serina S., Sosio M., and Stinchi S. Discovering novel antibacterial agents by high throughput screening. Front. Drug Design Discov. 1 (2005) 3-16
16. Donadio S., Busti E., Monciardini P., Bamonte R., Mazza P., Sosio M., and Cavaletti L. Sources of polyketides and nonribosomal peptides. In: Wohlleben W., Spelling T., and Müller-Thiemann B. (Eds). Biocombinatorial Approaches for Drug Finding (2005), Ernst Schering Research Foundation, Springer, Berlin 19-41
17. Donadio S., Monciardini P., and Sosio M. Polyketide synthases and nonribosomal peptide synthetases: The emerging view from bacterial genomics. Nat. Prod. Rep. 24 (2007) 1073-1109
18. Falk S.P., Ulijasz A.T., and Weisblum B. Differential assay for high-throughput screening of antibacterial compounds. J. Biomol. Screen. 12 (2007) 1102-1108
19. Fischer H.P., Brunner N.A., Wieland B., Paquette J., Macko L., Ziegelbauer K., and Freiberg C. Identification of antibiotic stress-inducible promoters: A systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery. Genome Res. 14 (2004) 90-98
20. Fossum S., De Pascale G., Weigel C., Messer W., Donadio S., and Skarstad K. A robust screen for novel antibiotics: Specific knockout of the initiator of bacterial DNA replication. FEMS Microbiol. Lett. 281 (2008) 210-214
21. Hu W., Sillaots S., Lemieux S., Davison J., Kauffman S., Breton A., Linteau A., Xin C., Bowman J., Becker J., et al. Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathog. 3 (2007) e24
22. Hunter-Cevera J.C., and Belt A. Isolation of cultures. In: Demain A.L., and Davies J.E. (Eds). Manual of Industrial Microbiology and Biotechnology. 2nd ed. (1999), ASM Press, Washington, DC 3-20
23. Janzen W.P. High Throughput Screening: Methods and Protocols Vol. 190 (2002), Humana Press
24. Jensen P.R., Gontang E., Mafnas C., Mincer T.J., and Fenical W. Culturable marine actinomycete diversity from tropical Pacific Ocean sediments. Environ. Microbiol. 7 (2005) 1039-1048
25. Ji Y., Zhang B., Van Horn S.F., Warren P., Woodnutt G., Burnham M.K., and Rosenberg M. Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293 (2001) 2266-2269
26. Koehn F.E. High impact technologies for natural products screening. Prog. Drug Res. 65 (2008) 177-210
27. Lam K.S. New aspects of natural products in drug discovery. Trends Microbiol. 15 (2007) 279-289
28. Lancini G. Forty years of antibiotic discovery at Lepetit: A personal journey. SIM News 56 (2006) 192-212
29. Larsen T.O., Smedsgaard J., Nielsen K.F., Hansen M.E., and Frisvad J.C. Phenotypic taxonomy and metabolite profiling in microbial drug discovery. Nat. Prod. Rep. 22 (2005) 672-695
30. Ling X.B. High throughput screening informatics. Comb. Chem. High Throughput Screen. 11 (2008) 249-257
31. Mishra K.P., Ganju L., Sairam M., Banerjee P.K., and Sawhney R.C. A review of high throughput technology for the screening of natural products. Biomed. Pharmacother. 62 (2008) 94-98
32. Otoguro M., Hayakawa M., Yamazaki T., and Iimura Y. An integrated method for the enrichment and selective isolation of Actinokineospora spp. in soil and plant litter. J. Appl. Microbiol. 91 (2001) 118-130
33. Payne D.J., Gwynn M.N., Holmes D.J., and Pompliano D.L. Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6 (2007) 29-40
34. Riedlinger J., Reicke A., Zähner H., Krismer B., Bull A.T., Maldonado L.A., Ward A.C., Goodfellow M., Bister B., Bischoff D., Süssmuth R.D., and Fiedler H.P. Abyssomicins, inhibitors of the para-aminobenzoic acid pathway produced by the marine Verrucosispora strain AB-18-032. J. Antibiot. 57 (2004) 271-279
35. Roemer T., Jiang B., Davison J., Ketela T., Veillette K., Breton A., Tandia F., Linteau A., Sillaots S., Marta C., Martel N., Veronneau S., et al. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol. Microbiol. 50 (2003) 167-181
36. Sakharkar K.R., Sakharkar M.K., and Chow V.T. Biocomputational strategies for microbial drug target identification. Method Mol. Med. 142 (2008) 1-9
37. Scott J.J., Oh D.C., Yuceer M.C., Klepzig K.D., Clardy J., and Currie C.R. Bacterial protection of beetle-fungus mutualism. Science 322 (2008) 63
38. Seringhaus M., Paccanaro A., Borneman A., Snyder M., and Gerstein M. Predicting essential genes in fungal genomes. Genome Res. 16 (2006) 1126-1135
39. Singh S.B., Phillips J.W., and Wang J. Highly sensitive target-based whole-cell antibacterial discovery strategy by antisense RNA silencing. Curr. Opin. Drug Discov. Devel. 10 (2007) 160-166
40. Ulijasz A.T., Grenader A., and Weisblum B. A vancomycin-inducible lacZ reporter system in Bacillus subtilis: Induction by antibiotics that inhibit cell wall synthesis and by lysozyme. J. Bacteriol. 178 (1996) 6305-6309
41. Urban A., Eckermann S., Fast B., Metzger S., Gehling M., Ziegelbauer K., Rübsamen-Waigmann H., and Freiberg C. Novel whole-cell antibiotic biosensors for compound discovery. Appl. Environ. Microbiol. 73 (2007) 6436-6443
42. Wang J., Soisson S.M., Young K., Shoop W., Kodali S., Galgoci A., Painter R., Parthasarathy G., Tang Y.S., Cummings R., Ha S., Dorso K., et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441 (2006) 358-361
43. Weinstein M.P. Micromonospora antibiotic discovery at Schering-Plough (1961-1973): A personal reminescence. SIM News 54 (2004) 56-66
44. Wölcke J., and Ullmann D. Miniaturized HTS technologies uHTS. Drug Discov. Today 6 (2001) 637-646